2014
DOI: 10.1016/j.archoralbio.2014.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Differences of isolated dental stem cells dependent on donor age and consequences for autologous tooth replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(18 citation statements)
references
References 39 publications
1
17
0
Order By: Relevance
“…Furthermore, DPSCs are non-tumourigenic even after their immortalisation by telomerase overexpression (Wilson et al, 2015). Finally, given that the dental pulp is rather well preserved in mid-to-advanced age patients, DPSCs are also suitable for autologous therapy (Ibarretxe et al, 2012;Kellner et al, 2014;Wu et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, DPSCs are non-tumourigenic even after their immortalisation by telomerase overexpression (Wilson et al, 2015). Finally, given that the dental pulp is rather well preserved in mid-to-advanced age patients, DPSCs are also suitable for autologous therapy (Ibarretxe et al, 2012;Kellner et al, 2014;Wu et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Several reports have indicated that a reduction in proliferative ability was strongly correlated with increasing age. For example, DPSCs derived from younger individuals showed faster doubling times than those from senior individuals [39]. In addition, with increasing age, dental stem cells underwent a decline in their capacity to perform neurogenic differentiation but an increase in their capacity to perform osteogenic differentiation in vitro [40, 41].…”
Section: Discussionmentioning
confidence: 99%
“…One of its major advantages is that maxilla-derived stem cells proliferation potential is probably unaffected by donor age, and only population doubling time seems to increase with donor age. 56 BM-MSC have already been used in the alveolar cleft regeneration on animal models [17][18][19][20][21][22] and in first clinical cases. 23-28 BM-MSC were by many investigators found suitable for craniofacial tissue engineering including calvarial bone defects 57-61 and both maxillary 62 and mandibular 63-67 bone reconstruction.…”
Section: Bone Marrow-derived Stem Cellsmentioning
confidence: 99%